Cargando…

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is usually diagnosed in an advanced stage and has become the second deadliest type of cancer worldwide. The systemic treatment of advanced HCC has been a challenge, and for decades was limited to treatment with tyrosine kinase inhibitors (TKIs) until the application of...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yue, Hu, Haoyue, Yuan, Xianglei, Fan, Xue, Zhang, Chengda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9226303/
https://www.ncbi.nlm.nih.gov/pubmed/35757756
http://dx.doi.org/10.3389/fimmu.2022.896752